ACR: Patients on long-term glucocorticoids should receive oral bisphosphonates
Patients receiving long-term glucocorticoids should use oral bisphosphonates to reduce the risk for bone loss and fracture, according to new guidelines currently under peer review from the American College of Rheumatology.